Furthermore, as the primary mechanism of genotoxic radio- and chemotherapy involves the p53-mediated activation of the mitochondrial death pathway, tumor cells develop therapy resistance by disabling this pathway e.g., via overexpression of antiapoptotic Bcl-2 proteins [33, 57]. The gene discussed is TP53; the disease is neoplasm.